Drawing for KROVOSPAS

USPTO serial 79206898

KROVOSPAS

Reviewed by CopyMark Law Group

Reg. 5440464Status 404
Filing date
Status date
Registration date
Apr 10, 2018
Examiner
RINKER, ANTHONY MICHAEL
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KROVOSPAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard M. LaBarge

Richard M. LaBarge Marshall, Gerstein & Borun LLP233 S. Wacker DriveSuite 6300Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Aconitine, namely, analgesics; alginates for pharmaceutical purposes; alginate dietary supplements; aldehydes for pharmaceutical purposes; amino acids for veterinary purposes; amino acids for medical purposes; analgesics; anaesthetics; antibiotics; first-aid boxes, filled; cotton for medical purposes; aseptic cotton; bandages for dressings; cotton sticks for medical purposes; cotton swabs for medical purposes; absorbent cotton for medical purposes; gallic acid for pharmaceutical purposes; panty liners; menstruation knickers; sanitary knickers; sanitary panties; menstruation bandages; sanitary pads; sanitary napkins; sanitary towels; menstruation tampons; sanitary tampons; hydrastine, namely, hemostatics for medical purposes; hydrastinine, namely, hemostatics for medical purposes; glycerine for medical purposes; dietetic sugar adapted for medical use; esters for pharmaceutical purposes for the treatment of hemophilia, hemorrhage and bleeding control; cellulose esters for pharmaceutical purposes; ethers for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; gelatine for medical purposes; chewing gum for medical purposes; dental mastics; dental cements; hyaluronic acids for pharmaceutical purposes; bone cement for surgical and orthopaedic purposes; medicated compresses; blood for medical purposes; haemostatic pencils; hemostatic pencils; lactose for pharmaceutical purposes; milk sugar for pharmaceutical purposes; lecithin for medical purposes; lecithin dietary supplements; adhesive bands for medical purposes; adhesive tapes for medical purposes; medicine cases, portable, filled, namely, medicines for the treatment of hemophilia, hemorrhage and bleeding control; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of hemophilia, hemorrhage and bleeding control; medicines for veterinary purposes for the treatment of hemophilia, hemorrhage and bleeding control; medicines for dental purposes; medicinal roots; medicinal tea; medicinal herbs; medicinal oils; liniments; gauze for dressings; teeth filling material; menthol for pharmaceutical purposes; mineral food supplements; mint for pharmaceutical purposes; cooling sprays for medical purposes; diapers for incontinents; napkins for incontinents; peptones for pharmaceutical purposes, namely, amino acids for medical purposes; medical dressings; blood plasma; adhesive plasters for medical purposes; sticking plasters for medical use; belts for sanitary napkins; haemorrhoid preparations; sunburn preparations for pharmaceutical purposes; preparations for the treatment of burns; mouthwashes for medical purposes; preparations of trace elements for human and animal use, namely, mineral supplements; antiseptic cotton; antiseptics; radioactive substances for medical purposes; diagnostic biomarker reagents for medical purposes; radiological contrast substances for medical purposes; suppositories; tissues impregnated with pharmaceutical lotions, namely, medicated pre-moistened tissues; siccatives for medical purposes; pharmaceutical preparations for skin care; phosphates for pharmaceutical purposes for the treatment of heart disease and metabolism correction; vine disease treating chemicals; chemical preparations for veterinary purposes for the treatment of hemophilia, hemorrhage and bleeding control chemical preparations for medical purposes for the treatment hemophilia, hemorrhage and bleeding control chemical preparations for pharmaceutical purposes for the treatment of hemophilia, hemorrhage and bleeding control surgical glues; and surgical dressingsSECTION 71 - CANCELLED—
010Aerosol dispensers for medical purposes; bandages, elastic; cupping glasses; dental burs; vaginal syringes; plaster support bandages for orthopedic purposes; surgical sponges; drainage tubes for medical purposes; inhalers for medical purposes; catheters; catgut for surgical use; suture materials; thread, surgical; knee bandages, orthopedic; orthopedic soles; orthopaedic belts; suspensory bandages, namely, supportive bandages; hypodermic syringes; bandages for joints, anatomical; supportive bandages; and receptacles for applying medicines, namely, medical syringesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 5, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 18, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 1, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 1, 2025INPCINVALIDATION PROCESSED—
Jun 25, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 25, 2024C71TCANCELLED SECTION 71—
Apr 10, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 24, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 27, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 27, 2018FIMPFINAL DISPOSITION PROCESSED—
Jul 10, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 10, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 19, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jan 3, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 3, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 18, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2017ALIEASSIGNED TO LIE—
Nov 8, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 5, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 5, 2017RFRRREFUSAL PROCESSED BY MPU—
May 23, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 22, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2017RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
May 13, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
May 10, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 9, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2017DOCKASSIGNED TO EXAMINER—
May 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance